Evidence map›Paper›PMID 27757297›Full record

ArticleOncoimmunology

Novel non-canonical role of STAT1 in Natural Killer cell cytotoxicity.

Eva Maria Putz, Andrea Majoros, Dagmar Gotthardt, Michaela Prchal-Murphy, Eva Maria Zebedin-Brandl, Daniela Alexandra Fux, Andreas Schlattl, Robert D Schreiber, Sebastian Carotta, Mathias Müller and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncoimmunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Gut microbes
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 3 countries.

Eva Maria PutzInstitute of Pharmacology and Toxicology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna , Vienna, Austria.
Andrea MajorosMax F. Perutz Laboratories, University of Vienna , Vienna, Austria.
Dagmar GotthardtInstitute of Pharmacology and Toxicology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna , Vienna, Austria.
Michaela Prchal-MurphyInstitute of Pharmacology and Toxicology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna , Vienna, Austria.
Eva Maria Zebedin-BrandlInstitute of Pharmacology, Center for Physiology and Pharmacology, Medical University of Vienna , Vienna, Austria.
Daniela Alexandra FuxInstitute of Pharmacology and Toxicology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna , Vienna, Austria.
Andreas SchlattlBoehringer Ingelheim RCV GmBH & CO KG , Vienna, Austria.
Robert D SchreiberDepartment of Pathology and Immunology, Washington University School of Medicine , St Louis, MO, USA.
Sebastian CarottaBoehringer Ingelheim RCV GmBH & CO KG, Vienna, Austria; Division of Molecular Immunology, Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; Department of Medical Biology, The University of Melbourne, Melbourne, Victoria, Australia.
Mathias MüllerInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria; Biomodels Austria, Vienna, Austria.
Christopher GernerDepartment of Analytical Chemistry, Faculty of Chemistry, University of Vienna , Vienna, Austria.
Thomas DeckerMax F. Perutz Laboratories, University of Vienna , Vienna, Austria.
Veronika SexlInstitute of Pharmacology and Toxicology, Department for Biomedical Sciences, University of Veterinary Medicine Vienna , Vienna, Austria.
University of Veterinary Medicine Vienna · ATBoehringer Ingelheim (Austria) · ATMax Perutz Labs · ATMedical University of Vienna · ATUniversity of Vienna · ATWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STAT1 is an important regulator of NK cell maturation and cytotoxicity. Although the consequences of

Indexed as

Interactome; NK cellSTAT1tumor surveillancevesicle

Identifiers

PMID27757297
PMCPMC5048756
OpenAlexW2400308155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.